Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: a National Cancer Institute of Canada Clinical Trials Group study.
about
Pharmacokinetically guided phase I trial of topotecan and etoposide phosphate in recurrent ovarian cancerPhase II study of 9-aminocamptothecin in previously treated lymphomas: results of Cancer and Leukemia Group B 9551.A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-upComeback for the camptothecins?Topotecan combined with Ifosfamide, Etoposide, and L-asparaginase (TIEL) regimen improves outcomes in aggressive T-cell lymphoma.
P2860
Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: a National Cancer Institute of Canada Clinical Trials Group study.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Phase II study of sequential t ...... a Clinical Trials Group study.
@ast
Phase II study of sequential t ...... a Clinical Trials Group study.
@en
type
label
Phase II study of sequential t ...... a Clinical Trials Group study.
@ast
Phase II study of sequential t ...... a Clinical Trials Group study.
@en
prefLabel
Phase II study of sequential t ...... a Clinical Trials Group study.
@ast
Phase II study of sequential t ...... a Clinical Trials Group study.
@en
P2093
P2860
P1433
P1476
Phase II study of sequential t ...... a Clinical Trials Group study.
@en
P2093
Andrew Maksymiuk
Brent Zanke
Elizabeth Eisenhauer
Leona Rudinskas
Michael Crump
Paul Hoskins
Ralph Meyer
Sarah Matthews
Stefan Gluck
Stephen Couban
P2860
P304
P356
10.1080/1042819021000002901
P577
2002-08-01T00:00:00Z